[Federal Register Volume 64, Number 68 (Friday, April 9, 1999)]
[Notices]
[Page 17399]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-8938]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Advisory Board to the National Center for Toxicological 
Research; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Science Advisory Board to the National Center 
for Toxicological Research (NCTR).
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 26, 1999, 12 noon 
to 5:30 p.m., and April 27, 1999, 8:30 a.m. to 1 p.m.
    Location: NCTR, Bldg. #12, Conference Center, Jefferson, AR.
    Contact Person: Ronald F. Coene, NCTR (HFT-10), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6696, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12559. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The board will be presented with draft reports on 
evaluations of three of NCTR's programs in Biochemical Toxicology, 
Genetic Toxicology, and Molecular Epidemiology, for their review, 
discussion, and approval. The draft reports are the products of three 
site visit teams who conducted on-site reviews over the last year. The 
staff from these programs will provide a preliminary response to the 
issues raised and recommendations made. Two progress reports will be 
presented to the board on the recommendations it made at its last 
meeting on NCTR's Neurotoxicology Program and Biometry and Risk 
Assessment Program. The NCTR Director will also provide a center 
update.
    Procedure: On April 26, 1999, from 12 noon to 5:30 p.m., and April 
27, 1999, from 8:30 a.m. to 12 noon, the meeting is open to the public. 
Interested persons may present data, information, or views, orally or 
in writing, on issues pending before the board. Written submissions may 
be made to the contact person by April 15, 1999. Oral presentations 
from the public will be scheduled between approximately 11 a.m. and 12 
noon on April 27, 1999. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person before April 15, 1999, and submit a brief statement 
of the general nature of the evidence or arguments they wish to 
present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Closed Committee Deliberations: On April 27, 1999, from 12 noon to 
1 p.m., the meeting will be closed to permit discussion where 
disclosure would constitute a clearly unwarranted invasion of personal 
privacy (5 U.S.C. 552b(c)(6)). This portion of the meeting will be 
closed to permit discussion of information concerning individuals 
associated with the research programs at NCTR.
    The Commissioner approves the scheduling of meetings at locations 
outside the Washington, DC area on the basis of the criteria of 21 CFR 
14.22 of FDA's regulations relating to public advisory committees.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 1, 1999.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 99-8938 Filed 4-8-99; 8:45 am]
BILLING CODE 4160-01-F